Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028738 (
nystagmus
)
7,431
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Retinal bipolar cells receive glutamatergic transmission from photoreceptors and mediate a key process in segregating visual signals into ON-center and OFF-center pathways. The segregation of ON responses involves a G protein-coupled metabotropic glutamate receptor (mGluR). The
mGluR6
subtype is expressed restrictedly at the postsynaptic site of retinal ON-bipolar cells. Ablation of
mGluR6
in the ON-bipolar cells by gene targeting results in a loss of ON responses but unchanged OFF responses in visual transmission. Thus,
mGluR6
is essential for inducing ON responses. The aims of this study are analyses of visual responsiveness and possible visual dysfunction in
mGluR6
-deficient mice. We report here that
mGluR6
-deficient mice have unaltered locomotor activity in a daily light-dark cycle and exhibit light-stimulated induction of Fos immunoreactivity in the suprachiasmatic nucleus. These findings indicate that
mGluR6
-deficient mice are capable or responding to light stimulation. The
mGluR6
deficiency, however, markedly reduces the sensitivity of pupillary responses to light stimulus and severely impairs the ability to drive optokinetic
nystagmus
in response to visual contrasts. This study thus demonstrates that
mGluR6
contributes to discrimination of visual contrasts.
...
PMID:Impairment of pupillary responses and optokinetic nystagmus in the mGluR6-deficient mouse. 914 50